| Literature DB >> 33138918 |
Henrik Renner1, Martha Grabos1, Katharina J Becker1,2, Theresa E Kagermeier1,2, Jie Wu3,4, Mandy Otto1,2, Stefan Peischard5, Dagmar Zeuschner6, Yaroslav TsyTsyura7, Paul Disse5, Jürgen Klingauf7, Sebastian A Leidel3,4, Guiscard Seebohm5, Hans R Schöler1,2, Jan M Bruder1.
Abstract
Three-dimensional (3D) culture systems have fueled hopes to bring about the next generation of more physiologically relevant high-throughput screens (HTS). However, current protocols yield either complex but highly heterogeneous aggregates ('organoids') or 3D structures with less physiological relevance ('spheroids'). Here, we present a scalable, HTS-compatible workflow for the automated generation, maintenance, and optical analysis of human midbrain organoids in standard 96-well-plates. The resulting organoids possess a highly homogeneous morphology, size, global gene expression, cellular composition, and structure. They present significant features of the human midbrain and display spontaneous aggregate-wide synchronized neural activity. By automating the entire workflow from generation to analysis, we enhance the intra- and inter-batch reproducibility as demonstrated via RNA sequencing and quantitative whole mount high-content imaging. This allows assessing drug effects at the single-cell level within a complex 3D cell environment in a fully automated HTS workflow.Entities:
Keywords: 3D cell culture; automation; forebrain; high content imaging; high throughput screening; human; midbrain; organoid; regenerative medicine; stem cells
Mesh:
Substances:
Year: 2020 PMID: 33138918 PMCID: PMC7609049 DOI: 10.7554/eLife.52904
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140